| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $408.7M | -8.8% |
| Cost of Revenue | $50.7M | -10.8% |
| R&D Expense | $9.9M | +12.2% |
| SG&A Expense | $90.7M | -27.5% |
| Operating Income | $89.0M | +71.8% |
| Pre-tax Income | $96.4M | +71.8% |
| Income Tax | $3.3M | +80.4% |
| Net Income | $7.1M | +296.1% |
| EPS (Basic) | $0.18 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97.9M | -36.9% |
| Accounts Receivable | $1.9M | -58.6% |
| Current Assets | $168.8M | -37.0% |
| Total Assets | $259.5M | -34.6% |
| Current Liabilities | $260.2M | -30.4% |
| Total Liabilities | $477.4M | -30.4% |
| Stockholders' Equity | -$12.5M | -13.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.1M | -135.5% |
| Capital Expenditures | $133K | +104.6% |
| Investing Cash Flow | -$681K | +64.1% |
| Financing Cash Flow | -$34.5M | +46.1% |
| Free Cash Flow | -$22.3M | -135.7% |
| +200.0% |
| EPS (Diluted) | $0.18 | +260.0% |